This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Patients are struggling to find the right care, and that’s because the healthcare system is fragmented, according to Andrea Walsh, president and CEO of HealthPartners, an integrated healthcareprovider and insurance company. Walsh made these comments Wednesday at the HIMSS 2023 conference in Chicago.
How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. The post Why Diversity Matters to Patients appeared first on InCrowd.
In 2023, expect manufacturers to further shift their focus away from acquiring new patient prescriptions to retaining existing customers. Ensuring patient access. Retaining business begins with patient access. Preventing patient drop-off. in 1979 to 2.8%in
In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. 9 Healthcare Marketing Trends 2023. The COVID-19 pandemic supercharged a new type of competition for legacy healthcare organizations.
In an increasingly digital healthcare landscape, keeping patients engaged has become a top priority for providers. One emerging strategy thats proving effective is gamification in healthcare. But how does gamification work in healthcare, and what are its benefits? billion dollars.
ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA with the theme, “Impacting Innovation, Value, and Healthcare Decision Making.”
Counterfeit medicines aren’t just a risk to patients’ health – they’re a blow to the industry’s reputation and our efforts to promote genuine, high-quality treatments. They often look like the real thing, making it hard for patients to tell the difference. What Are Counterfeit Medicines?
Patient-centricity taking center stage. Further, based on over a decade of feedback from thousands of healthcareprovider (HCP) advisors, across all therapeutic areas, we are consistently hearing that asynchronous engagements are the #1 preferred way of engaging with Big Pharma. . Product launches going virtual. Sustainability.
Search engine optimization sits at the heart of any successful healthcare marketing strategy. Therefore, it is essential to become familiar with the role SEO strategy plays in healthcare marketing and healthcare SEO best practices that should be employed in 2023 to create a successful digital marketing plan.
I joined Pfizer in January 2023 as a health access specialist, after working at Clalit Health Services in Israel for almost 20 years. At Clalit, which is the second largest healthcareprovider in the world, I worked in several management positions and gained a broad understanding of the needs and constraints of a healthcare system.
ISPOR—The Professional Society for Health Economics and Outcomes Research announced its ISPOR Real-World Evidence Summit 2023 scheduled for May 7 in Boston, MA, USA. The Summit is collocated with and being held immediately prior to the Society’s annual international conference, ISPOR 2023.
The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities. Combined, DTx and DCTs improve patient recruitment, retention, and access, allowing researchers to pull from underserved communities, including rural populations.
Within healthcare, harnessing data effectively is crucial for any organization striving to deliver exceptional patient care, drive operational efficiency, and remain competitive. Safe to say, the last several years have been extraordinarily difficult for health systems – in 2023 alone, 40% of health systems were not profitable.
Within healthcare, harnessing data effectively is crucial for any organization striving to deliver exceptional patient care, drive operational efficiency, and remain competitive. Safe to say, the last several years have been extraordinarily difficult for health systems – in 2023 alone, 40% of health systems were not profitable.
Empowering patients with comprehensive information about their health and medical conditions is a critical step towards fostering their active involvement in healthcare decisions. And pharma marketers can play a crucial role in helping to deliver the right education to patients.
Register for one of Impetus’ upcoming webinars between February 26-28: Top-5 Trends in Virtual KOL Engagement About the webinar We’re taking a look at the top trends from 2023 and share our predictions for the new year. She has a wide range of leadership experiences as a business development leader from small to big pharmaceutical companies.
Providers are already integrating Virtual Reality ( VR ) into patient care in a variety of ways. So, how do patients get access to this technology, and how do providers get paid for using it? Reimbursement impacts patient access, business and revenue models, investment potential, and product development.
The healthcare industry – along with the rest of the modern world – is witnessing a transformative shift with the integration of artificial intelligence (AI), reshaping the way providers interact with and care for patients.
This media becomes especially important in healthcare since it enables the clear, concise, and efficient communication of difficult medical ideas, techniques, and patient education resources. Medical video production is producing excellent videos, especially for the demands of the pharmaceutical, medical device, and healthcare sectors.
Here are our top three provider network optimization strategies for health plans seeking to gain market share and manage claims spend in 2023 and beyond. Use healthcareprovider data to boost network performance Assessing provider performance is one of the key challenges of network design and optimization.
Pharmaceutical brands often take a backseat role in patient health by encouraging patients to talk to their healthcareprovider about treatment options. However, today’s healthcare consumers are asking for a different approach. A Deeper Look Into the Digital Healthcare Journey.
At its heart, the point of care has always revolved around the when and where patients are making decisions about their health. Often, these moments are happening in the presence of their healthcareprovider (HCP), especially in-person at doctor’s offices. Put yourself in the shoes of your patients.
The much-anticipated 2023 Medicare Physician Fee Schedule Proposed Rule is here, and we covered everything you need to know in a one-hour webinar! How to Influence the Final Rule.
While this Bulletin was issued at the end of 2022, OCR and the FTC jointly issued a letter to over 130 companies in mid-2023 to notify them of these obligations, drawing widespread notice within the healthcare industry and broader business community.
London, UK (December 12, 2024) Global strategic partner in healthcare, Avalere Health, is proud to announce the appointment of Amar Urhekar as its new Chief Executive Officer (CEO). Clients need partners who can navigate the complex confluence of stakeholdersfrom healthcareproviders to payers, policymakers, and patients, said Urhekar.
The global healthcare IT market was valued at $280.3 1 This increased technology spending has led to industry fragmentation, creating siloed data—which can leave providers with an incomplete picture of a patient’s health record—and an often-cumbersome experience for patients, leaving them to shoulder the burden of managing their own care.
Today, there are some noticeable shifts for the better happening on the digital front, largely driven by healthcare consumerism and the demand that healthcare meet patients where they are – on their phones, in their homes, and outside the hospital.
Simply put, identifying a disorder and receiving a formal diagnosis is at the root of myriad difficulties—from connecting a patient to a community to generating an appropriate care and treatment plan that ideally goes beyond managing symptoms to connecting a patient to clinical trials.
In this year’s Proposed Rule (the “2023 Proposed Rule”), CMS proposed to cease payment for existing RTM CPT codes 98980 and 98981, add four new RTM HCPCS G codes, and add one new RTM CPT code to increase patient access to RTM services and reduce physician and nonphysician practitioner (“NPP”) supervisory burden.
New York Joins Growing Wave of State Health Privacy Laws If you think that patient health data is exclusively regulated by the Health Insurance Portability and Accountability Act (HIPAA) think again. In addition to comprehensive consumer privacy laws (e.g., How Does NYHIPA Compare to Washington States MHMDA?
Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients. In January 2023, VillageMD acquired Summit Health for $8.9
From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say. What are new and effective ways of engaging patients who are now using streaming services? In 2023, 55% of biopharma campaigns measured by Veeva Crossix included streaming, up 10% from 2022.
healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. states and the United Kingdom and sees more than 35 million patient encounters per year.
percent CAGR between 2023 and 2032. Consequently, this has led to “greater interest and investment in biosimilar development, as well as increased collaboration between biosimilar manufacturers and healthcareproviders to improve patient access and uptake”. million by 2032, at 17.6
From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. Looking back at 2023 , AI for drug discovery saw both wins and losses. The pharmaceutical industry has numerous use cases for AI. Despite new partnerships and increasing traction, there were some setbacks.
Sumitomo Pharma America (SMPA), a Sumitomo Pharma company, is focused on areas of critical patient need in oncology, urology, women’s health, rare disease, psychiatry, neurology, and cell & gene therapies. Patients SMPA is dedicated to partnering with stakeholders to increase patient access to medicine.
The artificial intelligence (AI) revolution has created a remarkable opportunity to transform medical diagnostics by significantly enhancing the accuracy, speed, and efficiency of diagnosing patients. They could help clinicians to navigate complex medical scenarios, optimize treatment strategies, and improve patient outcomes.
Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, side effects do happen.
With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start popping up. A version of this article was previously published in the Journal of mHealth. Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space.
Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression.
AstraZeneca’s first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. million patients worldwide with severe asthma who are uncontrolled, without any phenotypic and biomarker limitation.
Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. In addition, millions of their patients use GoodRx.
Like many industries, the pharmaceutical labour market has felt and will continue to feel the impacts of the COVID-19 pandemic moving into 2023 and beyond. Looking to the year ahead, here are some key challenges and solutions to keep in mind for a successful 2023 for recruiting, hiring, and retaining talent within a pharmaceutical company.
On 18 May 2023, the FDA announced the approval of Rinvoq (upadacitinib), AbbVie’s Janus kinase inhibitor (JAKi), to treat adults with moderately to severely active Crohn’s disease (CD) who have had an inadequate response or intolerance to one or more tumour necrosis factor (TNF) blockers.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content